Clinical Trial Update: Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) [NA]

View source ↗

Summary

Clinical trial update describing the safety and tolerability study of AXA1125 and AXA1957 in subjects with non-alcoholic fatty liver disease (NAFLD); trial comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• AXA1125 (AXA1125)
• AXA1957 (AXA1957)

Snippet

Sponsor: Axcella Health, Inc | Conditions: NAFLD | NA | Status: COMPLETED | Results posted: 2021-07-02